VEGFA and macular retinal edema: Here, evidence is provided that treatment for macular oedema with anti-VEGF injections may fail to provide sufficient clinical benefit for over 25% of patients by 9 months of treatment, 50% by 3 years and nearly 70% by 8 years in spite of appropriate loading.